News Overview

Bharat Dynamics has recorded a turnover of Rs 2700 crore provisional and unaudited for financial year ended 31 March 2022 compared to Rs 191376 crore in corresponding period of previous year

Infosys will announce results for the fourth quarter and year ended 31 March 2022 on 13 April 2022

Angel One announced that the Board of Directors of the Company at its meeting held on 1 April 2022 inter alia have recommended the fourth interim dividend of Rs 7 per equity Share ie 70Percentage subject to the approval of the shareholders

Deccan Health Care will hold a meeting of the Board of Directors of the Company on 9 April 2022

Dilip Buildcon has received revision in credit ratings for bank facilities and NCDs from CARE Ratings as under Long term bank facilities Rs 1940 crore – CARE A-; Stable revised from CARE A; Stable Long term short term bank facilities Rs 4500 crore – CARE A-; Stable CARE A2 revised from CARE A; Stable CARE A1 Non-convertible debentures Rs 300 crore – CARE A; Stable […]

V I P Industries has allotted 26516 equity shares under VIP Employees Stock Appreciation Rights Plan on 01 April 2022 With the allotment of the above shares the equity base of the Company stands increased from present level of 141473441 Nos to 141499957 Nos equity shares of Rs 2 each

Power Grid Corporation of India POWERGRID has transferred balance 26Percentage equity shareholding of POWERGRID Vizag Transmission PVTL to PGlnvlT on 31 March 2022 at a consideration of Rs 33078 crore after adjustments of dividend received by POWERGRID from PVTL With this POWERGRID has Nil shareholding in PVTL; and POWERGRID has relinquished its right on additional revenue accruing to POWERGRID Parli Transmission POWERGRID Warora Transmission and […]

Dr Reddys Laboratories has entered into an agreement with Novartis AG to acquire the cardiovascular brand Cidmus in India Under the agreement Dr Reddys will be assigned and transferred the Cidmus trademark in India from Novartis AG for a consideration of USD 61 million The Cidmus brand shall be affixed on the pharmaceutical composition comprising a combination of Valsartan and Sacubitril currently under Novartis patent […]

HCL Technologies will hold a meeting of the Board of Directors of the Company on 20 April 2022 and 21 April 2022

Srestha Finvest will hold a meeting of the Board of Directors of the Company on 5 April 2022